Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.9 (
ribonuclease
)
6,589
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
acid-labile subunit
(
ALS
) is a glycosylated 85-kDa member of the leucine-rich repeat (LRR) protein superfamily and circulates in ternary complexes with the insulin-like growth factors (IGFs) and their binding proteins (IGFBPs). These complexes are thought to regulate the serum IGFs by restricting IGF movement out of the circulation. However, little is known about how
ALS
binds to IGFBP-3 or -5, which link the IGFs to
ALS
. To investigate potential sites of interaction, the
ALS
structure has been modeled with the crystal structure of the LRR protein porcine
ribonuclease
inhibitor as a template.
ALS
is predicted to be a donut-shaped molecule with an internal diameter of 1.7 nm, an external diameter of 7.2 nm, and a thickness of 3.6 nm. These dimensions are supported by rotary shadowing electron microscopy of
ALS
. The internal face is lined with a substantial region of electronegative surface potential that could interact with the positively charged region on IGFBP-3 known to be involved in
ALS
binding. The model also predicts that three potential N-linked oligosaccharide sites within the LRR domain are clustered together, which may be important in light of recent studies showing
ALS
glycan involvement in complex formation with IGFBP-3.
...
PMID:The acid-labile subunit of the serum insulin-like growth factor-binding protein complexes. Structural determination by molecular modeling and electron microscopy. 1043 9
During the transition from pregnancy to lactation, dairy cows experience a 70% reduction in plasma IGF-I. This reduction has been attributed to decreased hepatic IGF-I production. IGF-I circulates predominantly in multi-protein complexes consisting of one molecule each of IGF-I, IGF binding protein-3 and the
acid labile subunit
(
ALS
). Recent studies in the mouse have shown that absence of
ALS
results in accelerated turnover and severely depressed concentration of plasma IGF-I. These observations suggest that reduced plasma
ALS
could be a second factor contributing to the fall of plasma IGF-I in peri-parturient cows. This possibility has not been studied due to the lack of bovine
ALS
reagents. To address this, we isolated the bovine
ALS
cDNA and used its sequence to develop a
ribonuclease
protection assay (RPA) and a bovine
ALS
antiserum. Using the RPA,
ALS
mRNA abundance was approximately fivefold higher in liver than in lung, small intestine, adipose tissue, kidney and heart, but was absent in muscle and brain. The antiserum detected the highest
ALS
levels in plasma followed by ovarian follicular fluid, lymph and colostrum. A portion of colostrum and follicular fluid
ALS
appears to be synthesized locally as
ALS
mRNA was found in mammary epithelial cells and ovarian follicular cells. Finally, we measured plasma
ALS
in dairy cows during the peri-parturient period (days -35 and +56 relative to parturition on day 0). Plasma
ALS
dropped by 50% between late pregnancy and the first day of lactation and returned to prepartum levels by day +56. To determine whether this reflected a change in hepatic expression,
ALS
mRNA was measured in liver biopsies collected on days -35, +3 and +56.
ALS
mRNA expression was significantly lower on day +3 than on day -35, but recovered completely by day +56. Finally, we examined the ability of GH to increase plasma
ALS
abundance at selected times before and after parturition (weeks -5, -2, +1 and +5). GH increased plasma
ALS
at weeks -5, -2 and +5, but not at week +1. Identical effects of GH were seen when the response considered was plasma IGF-I. We conclude that the decline in plasma
ALS
after parturition is a consequence of hepatic GH resistance and contributes to the associated reduction of plasma IGF-I.
...
PMID:Isolation of the cDNA encoding the acid labile subunit (ALS) of the 150 kDa IGF-binding protein complex in cattle and ALS regulation during the transition from pregnancy to lactation. 1673 89